Page last updated: 2024-08-23

meglitinide and biguanides

meglitinide has been researched along with biguanides in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's17 (80.95)29.6817
2010's4 (19.05)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirsch, IB; White, JA1
Feinglos, MN; Luna, B1
McCormick, M; Quinn, L1
Inzucchi, SE; Mayerson, AB1
Slocum, JM; Sosa, ME1
Muller, AA1
Adler, Y; Fisman, EZ; Motro, M; Tenenbaum, A1
Bell, DS1
Purnell, JQ; Weyer, C1
Car, J; Majeed, A; Patel, H; Srishanmuganathan, J1
Ratner, RE; Uwaifo, GI1
Levetan, C1
Scemons, D1
Modi, P1
Hermansen, K; Mortensen, LS1
Avery, MA; Chittiboyina, AG; Kurtz, TW; Mizuno, CS; Pershadsingh, HA1
Fisman, EZ; Motro, M; Tenenbaum, A1
Kopecky, C1
Kashyap, SR; Kattan, MW; Raghavan, D; Sun, GE; Wells, BJ; Yip, K; Zimmerman, R1
Abe, J; Hara, H; Kinosada, Y; Nagasawa, H; Nakamura, M; Nishibata, Y; Suzuki, Y; Umetsu, R1
Bailey, CJ; Barnett, AH; Tahrani, AA1

Reviews

18 review(s) available for meglitinide and biguanides

ArticleYear
Nonhypoglycemic drug reactions of agents used to treat diabetes.
    Endocrinology and metabolism clinics of North America, 2000, Volume: 29, Issue:4

    Topics: Benzamides; Biguanides; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles

2000
Oral agents in the management of type 2 diabetes mellitus.
    American family physician, 2001, May-01, Volume: 63, Issue:9

    Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2001
Treatment of type 2 diabetes mellitus: pharmacologic intervention.
    The Journal of cardiovascular nursing, 2002, Volume: 16, Issue:2

    Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2002
Type 2 diabetes therapy. A pathophysiologically based approach.
    Postgraduate medicine, 2002, Volume: 111, Issue:3

    Topics: alpha-Glucosidases; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones

2002
Use of antidiabetes agents in pregnancy: current practice and controversy.
    The Journal of perinatal & neonatal nursing, 2002, Volume: 16, Issue:2

    Topics: Administration, Oral; Benzamides; Biguanides; Diabetes, Gestational; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Polycystic Ovary Syndrome; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds; Thiazoles

2002
Managing pediatric ingestions of the new antidiabetic agents.
    Journal of emergency nursing, 2004, Volume: 30, Issue:2

    Topics: Benzamides; Biguanides; Child, Preschool; Emergency Medical Services; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Poisoning; Rosiglitazone; Thiazolidinediones

2004
Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Herz, 2004, Volume: 29, Issue:3

    Topics: Administration, Oral; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Drug Combinations; Glycoside Hydrolase Inhibitors; Heart; Heart Diseases; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome

2004
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approaches.
    Treatments in endocrinology, 2004, Volume: 3, Issue:2

    Topics: Animals; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Sulfonylurea Compounds; Thiazolidinediones

2004
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
    Treatments in endocrinology, 2003, Volume: 2, Issue:1

    Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Obesity; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain

2003
Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
    The American journal of cardiology, 2007, Feb-19, Volume: 99, Issue:4A

    Topics: Administration, Oral; Benzamides; Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones

2007
Oral antidiabetic agents in type 2 diabetes.
    Current medical research and opinion, 2007, Volume: 23, Issue:4

    Topics: Adenosine Deaminase Inhibitors; Administration, Oral; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Receptors, Glucagon; Sulfonylurea Compounds; Thiazolidinediones

2007
Are you up-to-date on diabetes medications?
    Nursing, 2007, Volume: 37, Issue:7

    Topics: Amyloid; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Monitoring; Exenatide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Patient Selection; Peptides; Sulfonylurea Compounds; Thiazolidinediones; Venoms

2007
Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus.
    Current drug discovery technologies, 2007, Volume: 4, Issue:1

    Topics: Administration, Inhalation; Benzamides; Benzoates; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Therapy, Combination; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazolidinediones

2007
Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Drug safety, 2007, Volume: 30, Issue:12

    Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Obesity; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain

2007
Type 2 diabetes and oral antihyperglycemic drugs.
    Current medicinal chemistry, 2008, Volume: 15, Issue:1

    Topics: Administration, Oral; Animals; Benzamides; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones

2008
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
    Advances in cardiology, 2008, Volume: 45

    Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones

2008
Use of noninsulin antidiabetic medications in hospitalized patients.
    Critical care nursing clinics of North America, 2013, Volume: 25, Issue:1

    Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones

2013
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
    Nature reviews. Endocrinology, 2016, Volume: 12, Issue:10

    Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones

2016

Other Studies

3 other study(ies) available for meglitinide and biguanides

ArticleYear
Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Journal of public health (Oxford, England), 2007, Volume: 29, Issue:1

    Topics: Administration, Oral; Benzamides; Biguanides; Blood Glucose Self-Monitoring; Diabetes Mellitus; Drug Costs; Drug Utilization; England; Equipment and Supplies; Family Practice; Health Care Costs; Humans; Hypoglycemic Agents; Insulin; Pharmacies; Sulfonylurea Compounds; Thiazolidinediones

2007
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
    Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:3

    Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Odds Ratio; Ohio; Proportional Hazards Models; Registries; Retrospective Studies; Risk; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones

2014
[Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2014, Volume: 134, Issue:2

    Topics: Acarbose; Administration, Oral; Adverse Drug Reaction Reporting Systems; Benzamides; Biguanides; Data Mining; Databases, Pharmaceutical; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Pyrazines; Risk; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles

2014